Information maintained by:
INCB
Webmaster
SCHEDULES
Revised Schedules including all amendments made by the Commission on Narcotic Drugs in Force as of 5 March 1990
List of Drugs Included in Schedule I
| Acetorphine | 3-O-acetyltetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endoetheno-oripavine |
| Acetyl-alpha-methylfentanyl | N-[1-(alpha-methylphenethyl)-4-piperidyl]acetanilide |
| Acetylmethadol | 3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| Alfentanil | N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide |
| Allylprodine | 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine |
| Alphacetylmethadol | alpha-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| Alphameprodine | alpha-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine |
| Alphamethadol | alpha-6-dimethylamino-4,4-diphenyl-3-heptanol |
| Alpha-methylfentanyl | N-[1(alpha-methylphenethyl)-4-piperidyl]propionanilide |
| Alpha-methylthiofentanyl | N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| Alphaprodine | alpha-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
| Anileridine | 1-para-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Benzethidine | 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Benzylmorphine | 3-O-benzylmorphine |
| Betacetylmethadol | beta-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| Beta-hydroxyfentanyl | N-[1-(beta-hydroxyphenethyl)-4-piperidyl]propionanilide |
| Beta-hydroxy-3-methylfentanyl | N-[1-(beta-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide |
| Betameprodine | beta-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine |
| Betamethadol | beta-6-dimethylamino-4,4-diphenyl-3-heptanol |
| Betaprodine | beta-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
| Bezitramide | 1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)-piperidine |
| Cannabis and Cannabis resin | and EXTRACTS and TICTURES OF CANNABIS |
| Clonitazene | 2-para-chlorbenzyl-1-diethylaminoethyl-5-nitrobenzimidazole |
| Coca leaf | |
| Cocaine | methyl ester of benzoylecgonine |
| Codoxime | dihydrocodeinone-6-carboxymethyloxime |
| Concentrate of poppy straw | the material arising when poppy straw has entered into a process for the concentration of its alkaloids when such material is made available in trade |
| Desomorphine | dihydrodeoxymorphine |
| Dextromoramide | (+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]-morpholine |
| Diampromide | N-[2-(methylphenethylamino)-propyl]propionanilide |
| Diethylthiambutene | 3-diethylamino-1,1-di-(2´-thienyl)-1-butene |
| Difenoxin | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid |
| Dihydromorphine | |
| Dimenoxadol | 2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate |
| Dimepheptanol | 6-dimethylamino-4,4-diphenyl-3-heptanol |
| Dimethylthiambutene | 3-dimethylamino-1,1-di-(2′-thienyl)-1-butene |
| Dioxaphetyl butyrate | ethyl-4-morpholino-2,2-diphenylbutyrate |
| Diphenoxylate | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Dipipanone | 4,4-diphenyl-6-piperidine-3-heptanone |
| Drotebanol | 3,4-dimethoxy-17-methylmorphinan-6-beta,14-diol |
| Ecgonine | its esters and derivatives which are convertible to ecgonine and cocaine |
| Ethylmethylthiambutene | 3-ethylmethylamino-1,1-di-(2´-thienyl)-1-butene |
| Etonitazene | 1-diethylaminoethyl-2-para-ethoxybenzyl-5-nitrobenzimidazole |
| Etorphine | tetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endoetheno-oripavine |
| Etoxeridine | 1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Fentanyl | 1-phenethyl-4-N-propionylanilinopiperidine |
| Furethidine | 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Heroin | diacetylmorphine |
| Hydrocodone | dihydrocodeinone |
| Hydromorphinol | 14-hydroxydihydromorphine |
| Hydromorphone | dihydromorphinone |
| Hydroxypethidine | 4-meta-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester |
| Isomethadone | 6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone |
| Ketobemidone | 4-meta-hydroxyphenyl-1-methyl-4-propionylpiperidine |
| Levomethorphan * | (-)-3-methoxy-N-methylmorphinan |
| Levomoramide | (-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)-butyl]morpholine |
| Levophenacylmorphan | (1)-3-hydroxy-N-phenacylmorphinan |
| Levorphanol * | (-)-3-hydroxy-N-methylmorphinan |
| Metazocine | 2′-hydroxy-2,5,9-trimethyl-6,7-benzomorphan |
| Methadone | 6-dimethylamino-4,4-diphenyl-3-heptanone |
| Methadone intermediate | 4-cyano-2-dimethylamino-4,4-diphenylbutane |
| Methyldesorphine | 6-methyl-delta-6-deoxymorphine |
| Methyldihydromorphine | 6-methyldihydromorphine |
| 3-methylfentanyl | N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide |
| 3-methylthiofentanyl | N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| Metopon | 5-methyldihydromorphinone |
| Moramide intermediate | 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid |
| Morpheridine | 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Morphine | |
| Morphine methobromide | and other pentavalent nitrogen morphine derivatives, including in particular the morphine-N-oxide derivatives, one of which is codeine-N-oxide |
| Morphine-N-oxide | |
| MPPP | 1-methyl-4-phenyl-4-piperidinol propionate (ester) |
| Myrophine | myristylbenzylmorphine |
| Nicomorphine | 3,6-dinicotinylmorphine |
| Noracymethadol | (±)-alpha-3-acetoxy-6-methylamino-4,4-diphenylheptane |
| Norlevorphanol | (-)-3-hydroxymorphinan |
| Normethadone | 6-dimethylamino-4,4-diphenyl-3-hexanone |
| Normorphine | demethylmorphine or N-demethylated morphine |
| Norpipanone | 4,4-diphenyl-6-piperidino-3-hexanone |
| Opium | |
| Oxycodone | 14-hydroxydihydrocodeinone |
| Oxymorphone | 14-hydroxydihydromorphinone |
| Para-fluorofentanyl | 4′-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide |
| PEPAP | 1-phenethyl-4-phenyl-4-piperidinol acetate (ester) |
| Pethidine | 1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Pethidine intermediate A | 4-cyano-1-methyl-4-phenylpiperidine |
| Pethidine intermediate B | 4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Pethidine intermediate C | 1-methyl-4-phenylpiperidine-4-carboxylic acid |
| Phenadoxone | 6-morpholino-4,4-diphenyl-3-heptanone |
| Phenampromide | N-(1-methyl-2-piperidinoethyl)-propionanilide |
| Phenazocine | 2′-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan |
| Phenomorphan | 3-hydroxy-N-phenethylmorphinan |
| Phenoperidine | 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| Piminodine | 4-phenyl-1-(3-phenylaminopropyl)-piperidine-4-carboxylic acid ethyl ester |
| Piritramide | 1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)-piperidine-4-carboxylic acid amide |
| Proheptazine | 1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane |
| Properidine | 1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester |
| Racemethorphan | (±)-3-methoxy-N-methylmorphinan |
| Racemoramide | (±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)-butyl]-morpholine |
| Racemorphan | (±)-3-hydroxy-N-methylmorphinan |
| Sufentanil | N-[4-(methoxymethyl)-1-[2-(2-thienyl)-ethyl]-4-piperidyl]propionanilide |
| Thebacon | acetyldihydrocodeinone |
| Thebaine | |
| Thiofentanyl | N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| Tilidine | (±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate |
| Trimeperidine | 1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine; and |
The isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;
The esters and ethers, unless appearing in another Schedule, of the drugs in this Schedule whenever the existence of such esters or ethers is possible;
The salts of the drugs listed in this Schedule, including the salts of esters, ethers and isomers as provided above whenever the existence of such salts is possible.
* Dextromethorphan ((+)-3-methoxy-N-methylmorphinan) and dextrorphan ((+)-3-hydroxy-N-methylmorphinan) are specifically excluded from this Schedule.
List of Drugs Included in Schedule II
| Acetyldihydrocodeine | |
| Codeine | 3-O-methylmorphine |
| Dextropropoxyphene | alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate |
| Dihydrocodeine | |
| Ethylmorphine | 3-O-ethylmorphine |
| Nicocodine | 6-nicotinylcodeine |
| Nicodicodine | 6-nicotinyldihydrocodeine |
| Norcodeine | N-demethylcodeine |
| Pholcodine | morpholinylethylmorphine |
| Propiram | N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide; and |
The isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;
The salts of the drugs listed in this Schedule, including the salts of the isomers as provided above whenever the existence of such salts is possible.
List of Preparations Included in Schedule III
| 1. Preparations of | Acetyldihydrocodeine, |
| Codeine, | |
| Dihydrocodeine, | |
| Ethylmorphine, | |
| Nicodicodine, | |
| Norcodeine, and | |
| Pholcodine |
2. Preparations of Propiram containing not more than 100 milligrams of propiram per dosage unit and compounded with at least the same amount of methylcellulose.
3. Preparations of Dextropropoxyphene for oral use containing not more than 135 milligrams of dextropropoxyphene base per dosage unit or with a concentration of not more than 2.5 per cent in undivided preparations, provided that such preparations do not contain any substance controlled under the 1971 Convention on Psychotropic Substances.
4. Preparations of Cocaine containing not more than 0.1 per cent of cocaine calculated as cocaine base and preparations of opium or morphine containing not more than 0.2 per cent of morphine calculated as anhydrous morphine base and compounded with one or more other ingredients and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health.
5. Preparations of Difenoxin containing, per dosage unit, not more than 0.5 milligram of difenoxin and a quantity of atropine sulfate equivalent to at least 5 per cent of the dose of difenoxin.
6. Preparations of Diphenoxylate containing, per dosage unit, not more than 2.5 milligrams of diphenoxylate calculated as base and a quantity of atropine sulfate equivalent to at least 1 per cent of the dose of diphenoxylate.
7. Preparations of Pulvis ipecacuanhae et opii compositus
10 per cent opium in powder
10 per cent ipecacuanha root, in powder
well mixed with
80 per cent of any other powdered ingredient containing no drug.
8. Preparations conforming to any of the formulas listed in this Schedule and mixtures of such preparations with any material which contains no drug.
List of Drugs Included in Schedule IV
| Acetorphine | 3-O-acetyltetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endoetheno-oripavine |
| Acetyl-alpha-methylfentanyl | N-[1-(alpha-methylphenethyl)-4-piperidyl]acetanilide |
| Alpha-methylfentanyl | N-[1-(alpha-methylphenethyl)-4-piperidyl]propionanilide |
| Alpha-methylthiofentanyl | N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| Beta-hydroxy-3-methylfentanyl | N-[1-(beta-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide |
| Beta-hydroxyfentanyl | N-[1-(beta-hydroxyphenethyl)-4-piperidyl]propionanilide |
| Cannabis and Cannabis resin | |
| Desomorphine | dihydrodeoxymorphine |
| Etorphine | tetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endoetheno-oripavine |
| Heroin | diacetylmorphine |
| Ketobemidone | 4-meta-hydroxyphenyl-1-methyl-4-propionylpiperidine |
| 3-methylfentanyl | N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide; cis–N-[3-methyl-1(2-phenylethyl)-4-piperidyl]propionanilide; trans–N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]propionanilide |
| 3-methylthiofentanyl | N-(3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| MPPP | 1-methyl-4-phenyl-4-piperidinol propionate (ester) |
| Para-fluorofentanyl | 4′-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide |
| PEPAP | 1-phenethyl-4-phenyl-4-piperidinol acetate (ester) |
| Thiofentanyl | N-[1-[2-(thienyl)ethyl]-4-piperidyl]propionanilide; and |
The salts of the drugs listed in this Schedule whenever the formation of such salts is possible.
|
Information maintained by: |